Business Description
Akso Health Group
SIC : 6141
ISIN : US4282951098
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 243.35 | |||||
Equity-to-Asset | 0.97 | |||||
Debt-to-EBITDA | -0.04 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 36.12 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -13.8 | |||||
3-Year EPS without NRI Growth Rate | 9.4 | |||||
3-Year FCF Growth Rate | -63.9 | |||||
3-Year Book Growth Rate | -3.6 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 25.58 | |||||
9-Day RSI | 31.61 | |||||
14-Day RSI | 37.47 | |||||
6-1 Month Momentum % | 36.43 | |||||
12-1 Month Momentum % | -25.97 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 39.52 | |||||
Quick Ratio | 39.46 | |||||
Cash Ratio | 23.7 | |||||
Days Inventory | 164.7 | |||||
Days Sales Outstanding | 1080.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -107.6 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 5.05 | |||||
Operating Margin % | -357.68 | |||||
Net Margin % | -391.68 | |||||
FCF Margin % | 55.74 | |||||
ROE % | -18.63 | |||||
ROA % | -15.82 | |||||
ROIC % | -46.2 | |||||
3-Year ROIIC % | -15.83 | |||||
ROC (Joel Greenblatt) % | -17.07 | |||||
ROCE % | -17.87 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 18.16 | |||||
PB Ratio | 0.94 | |||||
Price-to-Tangible-Book | 0.94 | |||||
Price-to-Free-Cash-Flow | 46.83 | |||||
Price-to-Operating-Cash-Flow | 46.83 | |||||
EV-to-EBIT | -22.6 | |||||
EV-to-EBITDA | -22.6 | |||||
EV-to-Revenue | 85.07 | |||||
EV-to-FCF | 152.06 | |||||
Price-to-Projected-FCF | 0.29 | |||||
Price-to-Net-Current-Asset-Value | 0.94 | |||||
Price-to-Net-Cash | 1.6 | |||||
Earnings Yield (Greenblatt) % | -4.42 | |||||
FCF Yield % | 0.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Akso Health Group Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 2.237 | ||
EPS (TTM) (€) | -0.179 | ||
Beta | -1.87 | ||
Volatility % | 153.14 | ||
14-Day RSI | 37.47 | ||
14-Day ATR (€) | 0.046478 | ||
20-Day SMA (€) | 0.89325 | ||
12-1 Month Momentum % | -25.97 | ||
52-Week Range (€) | 0.51 - 2.34 | ||
Shares Outstanding (Mil) | 240.87 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Akso Health Group Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Akso Health Group Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Akso Health Group Frequently Asked Questions
What is Akso Health Group(STU:8HX1)'s stock price today?
When is next earnings date of Akso Health Group(STU:8HX1)?
Does Akso Health Group(STU:8HX1) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |